Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The active compound reaches target tissues intact
You Don't Know What's in the Vial Third-party testing of "research" peptides has found: wrong peptide entirely, incorrect concentrations (sometimes 50% under or over), bacterial endotoxins, heavy metal contamination, and residual solvents from manufacturing
This dynamic produced a largely unregulated online marketplace where telehealth companies and other sellers mass-produced and widely promoted compounded GLP-1 drugs containing a different source of the active pharmaceutical ingredient (what drugs are made from), meaning the compounded versions were not the same and according to the FDA, could contain incorrect doses, too much or too little of the active ingredient, and possibly contaminants and bacteria
While promising, these small samples cannot establish efficacy
